U4 12 Pill - yellow capsule/oblong, 16mm
Pill with imprint U4 12 is Yellow, Capsule/Oblong and has been identified as Acetaminophen and Hydrocodone Bitartrate 325 mg / 10 mg. It is supplied by Upsher-Smith Laboratories Inc.
Acetaminophen/hydrocodone is used in the treatment of Back Pain; Pain; Cough and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Acetaminophen/hydrocodone 325 mg / 10 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for U4 12
Acetaminophen and Hydrocodone Bitartrate
- Imprint
- U4 12
- Strength
- 325 mg / 10 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Upsher-Smith Laboratories Inc.
- National Drug Code (NDC)
- 00245-0412
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
corn starch,
stearic acid,
D&C Yellow No. 10
Note: Inactive ingredients may vary.
Related images for "U4 12"
More about acetaminophen / hydrocodone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,313)
- Drug images
- Latest FDA alerts (11)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: narcotic analgesic combinations
- En español
Patient resources
- Hydrocodone and Acetaminophen drug information
- Hydrocodone and Acetaminophen Liquid
- Hydrocodone and Acetaminophen Tablets and Capsules
Other brands
Norco, Vicodin, Lortab, Lorcet, ... +11 more
Professional resources
- Hydrocodone Bitartrate and Acetaminophen Oral Solution prescribing information
- Hydrocodone and Acetaminophen (FDA)
- Hydrocodone and Acetaminophen Capsules (FDA)
- Hydrocodone and Acetaminophen Elixir (FDA)
- Hydrocodone and Acetaminophen Oral Solution (FDA)
Other brands
Norco, Vicodin, Lortab, Hycet, ... +8 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
